# Jay S. Skyler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jay-s-skyler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,795 |
| Field | Diabetes Management and Research |
| h-index | 76 |
| i10-index | 228 |
| Last Known Institution | University of Miami |
| OpenAlex ID | https://openalex.org/A5023214700 |
| ORCID iD | 0000-0003-1136-8110 |
| Works | 472 |

## Researcher papers

Showing 12 of 14.

- [Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association](https://scholariq.org/papers/staging-presymptomatic-type-1-diabetes-a-scientific-statement-of-jdrf-the/)
- [An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes](https://scholariq.org/papers/an-anti-cd3-antibody-teplizumab-in-relatives-at-risk-for-type-1-diabetes/)
- [Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function](https://scholariq.org/papers/rituximab-b-lymphocyte-depletion-and-preservation-of-beta-cell-function/)
- [Practical recommendations for the management of diabetes in patients with COVID-19](https://scholariq.org/papers/practical-recommendations-for-the-management-of-diabetes-in-patients-with-covid/)
- [Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials](https://scholariq.org/papers/intensive-glycemic-control-and-the-prevention-of-cardiovascular-events-2/)
- [Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis](https://scholariq.org/papers/differentiation-of-diabetes-by-pathophysiology-natural-history-and-prognosis/)
- [The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/the-management-of-type-1-diabetes-in-adults-a-consensus-report-by-the-american/)
- [Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/co-stimulation-modulation-with-abatacept-in-patients-with-recent-onset-type-1/)
- [C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function](https://scholariq.org/papers/c-peptide-is-the-appropriate-outcome-measure-for-type-1-diabetes-clinical-trials/)
- [Validation of the insulin sensitivity index (ISI0,120): comparison with other measures](https://scholariq.org/papers/validation-of-the-insulin-sensitivity-index-isi0-120-comparison-with-other/)
- [Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials](https://scholariq.org/papers/intensive-glycemic-control-and-the-prevention-of-cardiovascular-events/)
- [Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials](https://scholariq.org/papers/empagliflozin-as-adjunctive-to-insulin-therapy-in-type-1-diabetes-the-ease/)

## Researcher topics

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

## Researcher university

- [University of Miami](https://scholariq.org/institutions/university-of-miami/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.